Compass Therapeutics(CMPX) - 2025 Q1 - Quarterly Results

EXHIBIT 99.1 Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical- stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today reported first quarter 2025 financial results and provided a business update. "We're proud of the progress we've made this quarter, especially the achievement of the primary endpoint in our COMPANION ...